Actually, CNN, Bringing Back Brian 'The Potato' Stelter Won't Save Your Floundering Networ...
RIP Your Mentions: Matt Gertz of MMFA Realizes He's in for a Wild...
Sen. John Fetterman Calls Trump’s Nominations ‘God-Tier-Level Trolling
Smells Like RETRIBUTION to Us! After Polymarket Predicted Trump Win, FBI Raids Home...
Bucks County Democratic Officials Decide to Count Illegal Ballots and Admit They Don't...
Don't Let the Door Hit Ya! Eva Longoria Has Moved Family Out of...
AP, Decision Desk HQ Call PA Senate Race, but Dems Are Still Trying...
Florida AG Ashely Moody Is Going to Make Sure FEMA Answers for Discriminating...
CNN Panel Left Speechless After Scott Jennings Defends 'American Hero' Pete Hegseth
Make Enforcing Laws Great Again! Seattle (Yes, SEATTLE) Starts Jailing Shoplifters, Other...
Dem Rep. Dan Goldman Took the Bait After Trump Joked About Running Again...
Yes. I'm Embarrassed That YOU'RE an American, Frothy-Mouthed Leftist. Does That COUNT?
Nature Is Healing: X Users Notice AOC Has Removed Pronouns From Her Bio
JD Vance Has Our Betters Clutching All SORTS of Pearls With BRUTAL Merrick...
Trump Wages War on the Deep State! Sends Shockwave Through DC!

HHS explains purchase of $290 million worth of 'drug for use in radiological and nuclear emergencies'

The Department of Health & Human Services’ Administration for Strategic Preparedness & Response now has a statement on a web page about a recent $290 million purchase. Perhaps this kind of thing is fairly routine (the program started in 2004) but considering what’s going on in the world this has caught some attention:

Advertisement

Hey, you can never be too careful in the “Build Back Better” era now that America is so much more respected on the world stage!

From the ASPR’s section of the HHS’s website:

As part of long-standing, ongoing efforts to be better prepared to save lives following radiological and nuclear emergencies, the U.S. Department of Health and Human Services is purchasing a supply of the drug Nplate from Amgen USA Inc; Nplate is approved to treat blood cell injuries that accompany acute radiation syndrome in adult and pediatric patients (ARS).

Amgen, based in Thousands Oaks, California, developed Nplate for ARS with support from the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Administration for Strategic Preparedness and Response (ASPR), as well as the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

BARDA is using its authority provided under the 2004 Project Bioshield Act and $290 million in Project BioShield designated funding to purchase this supply of the drug. Amgen will maintain this supply in vendor-managed inventory. This approach decreases life-cycle management costs for taxpayers because doses that near expiration can be rotated into the commercial market for rapid use prior to expiry and new doses can be added to the government supply.

Advertisement

Some skepticism has ensued:


https://twitter.com/SojournerMrs/status/1577781523809505280

You know what’s coming next:

It’s going to be so important that any future nuclear war is kept as “equitable” as possible.
***

Related:

HHS Secretary Xavier Becerra says his department is continuing to explore opening abortion clinics on federal land

HHS Secretary Xavier Becerra supports government funding of gender affirming surgeries on minors

***

Editor’s Note:

Help us keep owning the libs! Join Twitchy VIP and use promo code AMERICAFIRST to receive a 25% discount off your membership!

Join the conversation as a VIP Member

Recommended

Trending on Twitchy Videos

Advertisement
Advertisement
Advertisement